论文部分内容阅读
为降低膀胱癌术后复发率,对24例患者采用术中切缘注射白细胞介素2(IL2)和术后膀胱灌注卡介苗(BCG)及IL2治疗。随访6~66个月,复发率为12.5%。认为此方法预防膀胱肿瘤术后复发安全有效。
To reduce the postoperative recurrence rate of bladder cancer, 24 patients were treated with intraoperative injection of interleukin-2 (IL-2) and postoperative bladder perfusion of BCG and IL-2. Followed up for 6 to 66 months, the recurrence rate was 12.5%. It is considered that this method is safe and effective in preventing postoperative recurrence of bladder tumors.